LUCY
INNOV EYEWEAR (LUCY)
NASDAQ
$0.76+$0.03 (+4.55%)
Price as of Jun 23, 2026 7:36 PM EDT
  • $4.7M
    Market Cap
  • -70.69%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
2.7M
+62.65%
1.6M
+41.99%
1.2M
+74.67%
659,788
N/A
Cost of Revenue
2.1M
+47.35%
1.4M
+11.75%
1.3M
+77.61%
716,077
N/A
Gross Profit
567,451
+163.70%
215,190
+280.33%
-119,329
+111.99%
-56,289
N/A
Sales and Marketing Expense
3.0M
+9.79%
2.7M
+32.20%
2.0M
-0.58%
2.1M
N/A
Research and Development Expense
-725,388
-11.47%
-819,387
+23.74%
-662,184
+26.20%
-524,692
N/A
Depreciation and Amortization Expense
68,554
+71.83%
39,897
+65.11%
24,164
+130.88%
10,466
N/A
Total Operating Expenses
9.1M
+11.35%
8.1M
+20.82%
6.7M
+22.02%
5.5M
N/A
Operating Profit
N/A
N/A
N/A
N/A
-6.7M
+17.28%
-5.7M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-3,036
-97.11%
-105,171
N/A
Interest Income and Expense and Net
0
N/A
0
+100.00%
-3,036
-97.11%
-105,171
N/A
Total Nonoperating Income and Expense
903,775
+474.97%
157,187
-18.18%
192,114
+82.67%
105,171
N/A
Income before Taxes
N/A
N/A
N/A
N/A
-6.7M
+17.28%
-5.7M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-6.7M
+17.28%
-5.7M
N/A
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
-6.7M
+17.28%
-5.7M
N/A
Basic EPS and Net Income
-1.90
-63.39%
-5.19
+723.81%
-0.63
N/A
N/A
N/A
Diluted EPS and Net Income
-1.90
-63.39%
-5.19
+723.81%
-0.63
N/A
N/A
N/A
Basic Weighted Average Shares
4.0M
+166.77%
1.5M
-85.77%
10.5M
N/A
N/A
N/A
Diluted Weighted Average Shares
4.0M
+166.77%
1.5M
-85.77%
10.5M
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
6.5M
+147.66%
2.6M
-38.68%
4.3M
+19.39%
3.6M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
6.5M
+147.66%
2.6M
-38.68%
4.3M
+19.39%
3.6M
N/A
Total Current Assets
9.4M
+2.13%
9.2M
+64.48%
5.6M
+32.45%
4.2M
N/A
Accumulated Depreciation
257,254
+35.07%
190,466
+135.21%
80,977
+258.32%
22,599
N/A
Property and Plant and Equipment and Net
61,777
-42.57%
107,562
-19.03%
132,848
+10.94%
119,744
N/A
Total Long-Term Assets
83,075
+101.50%
41,229
-43.25%
72,644
-11.17%
81,779
N/A
Total Assets
10.1M
+3.07%
9.8M
+58.20%
6.2M
+32.60%
4.7M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
61,356
N/A
Total Current Liabilities
1.0M
+41.69%
737,718
+18.13%
624,486
+4.08%
600,005
N/A
Total Long-Term Debt
300,000
-60.94%
768,000
-7.06%
826,356
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
5,450
-84.63%
35,450
-45.84%
65,450
N/A
Total Liabilities
1.1M
+44.49%
743,168
+12.61%
659,936
-0.83%
665,455
N/A
Retained Earnings
-32.3M
+30.69%
-24.7M
+45.77%
-17.0M
+64.66%
-10.3M
N/A
Total Stockholders Equity
9.1M
-0.32%
9.1M
+63.62%
5.6M
+38.13%
4.0M
N/A
Total Shares Outstanding
5.5M
+123.43%
2.5M
-81.01%
12.9M
+76.78%
7.3M
N/A
Cash Flow
Cash from Operating Activities
-7.3M
+7.95%
-6.7M
+16.88%
-5.8M
+78.83%
-3.2M
N/A
Capital Expenditures
72,513
+16.57%
62,203
-20.72%
78,463
-35.45%
121,561
N/A
Cash from Investing Activities
4.5M
+186.71%
-5.2M
+2,497.27%
-198,753
-9.64%
-219,951
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.7M
-34.77%
10.2M
+53.77%
6.7M
-4.23%
7.0M
N/A
Financials Ratio
Gross Margin
21.32%
+62.13%
13.15%
+227.00%
-10.35%
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-578.18%
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-122.17%
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
-139.06%
N/A
N/A
N/A
Revenue Growth
62.65%
+49.19%
41.99%
-43.76%
74.67%
N/A
N/A
N/A
Current Ratio
9.03
-27.92%
12.52
+39.23%
8.99
N/A
N/A
N/A
Cash Ratio
6.23
+74.78%
3.56
-48.09%
6.87
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow